Our Compounds
Set 1: |
Epigenetically Active |
Set 2: |
NeuroActive |
Set 3: |
Ser/Thr Kinase pathways |
||
Common Name |
MOA |
Common Name |
MOA |
Common Name |
MOA |
||
DMSO |
negative control |
DMSO |
negative control |
DMSO |
negative control |
||
GSK1210151A |
Bromodomain inhibitor; BRD2,3,4 |
Etoposide |
Top2B inhibitor, DNA DSB inducer |
Selumetinib |
Mek1/2 inhibitor |
||
GSK525762A |
Bromodomain inhibitor; BRD2,3,4 |
KU-55933 |
ATM inhibitor |
PD0325901 |
Mek1/2 inhibitor |
||
jq1 |
Bromodomain inhibitor; BRD4 |
SMER-3 |
E3 ligase inhibitor |
Everolimus |
mTOR inhibitor |
||
zebularine |
DNMT1 inhibitor |
ruxolitinib |
JAK 1 & 2 inhibitor |
vemurafenib |
Raf inhibitor |
||
decitabine |
DNMT1 inhibitor |
niclosamide |
STAT3 signaling inhibitor |
TG101348 |
Jak2 inhibitor |
||
EPZ-5676 |
DOT1L inhibitor |
VU0155056 |
inhibitor of phospholipase D1/D2 |
Tofacitinib |
Jak3 inhibitor |
||
EPZ004777 |
DOT1L inhibitor |
tacrolimus |
inhibitor of calcineurin |
Pravastatin |
Stat1 inhibitor |
||
gsk126 |
EHZ2 inhibitor |
tretinoin |
Retinoic Acid Receptor agonist |
SCH 900776 |
Rep. stress/CHK1 inhibitor |
||
EPZ-5687 |
EHZ2 inhibitor |
curcumin |
NFkB inhibitor |
flavopiridol |
CDK inhibitor |
||
CPI-169 |
EHZ2 inhibitor |
semagacestat |
gamma secretase inhibitor |
PD-0332991 |
CDK/4,6 inhibitor |
||
UNC0646 |
G9a inhibitor |
dexamethasone |
Glucocorticoid receptor agonist |
Dinaciclib |
CDK/1,2,5,9 inhibitor |
||
UNC0321 |
G9a inhibitor |
Olaparib |
PARP inhibitor |
RO4929097 |
Notch/gamma secretase inhibitor |
||
BIX 01338 |
G9a inhibitor |
bafilomycin A1 |
inhibitor of the vacuolar-type H+-ATPase |
BMS-906024 |
Notch/other inhibitor |
||
BIX 01294 |
G9a inhibitor; ? also kinase inhibitor (mTOR) |
Exifone |
Antioxidant |
Verteporfin |
Hippo inhibitor |
||
vorinostat |
HDAC inhibitor; general |
vorinostat |
HDAC inhibitor; general |
SP600125 |
Jnk inhibitor |
||
entinostat (MS275) |
HDAC inhibitor; general |
KN-62 |
CaMKIIalpha inhibitor |
vorinostat |
HDAC inhibitor; general |
||
tacedinaline (Ci-994) |
HDAC inhibitor; general |
calpain inhibitor II |
calpain inhibitor |
CC-401 |
Jnk inhibitor |
||
trichostatin-a |
HDAC inhibitor; general |
C646 |
CBP/p300 inhibitor |
VX-970 |
Rep. stress/ATR inhibitor |
||
belinostat |
HDAC inhibitor; general |
Compound E |
gamma secretase inhibitor |
losmapimod |
p38 MAPK inhibitor |
||
methylstat |
JHDM inhibitor (Jumonji C) |
KN-93 |
CaMKII/CaMKIV inhibitor |
PRI-724 |
Notch/Wnt/Hedgehog inhibitor |
||
GSK-J4 |
JMJD3 inhib |
Gossypetin |
HDAC1 activator |
dactolisib |
Ras/PI3K inhibitor |
||
UNC1215 |
L3MBTL3 probe |
Ginkgetin |
HDAC1 activator |
afuresertib |
Ras/AKT inhibitor |
||
1271738-62-5 (MI-2) |
MLL inhibitor |
Okadaic Acid |
PP1 and PP2a inhibitor |
BYL719 |
Ras/PI3K-P110a inhibitor |
||
OSI-027 |
mTOR inhibitor |
momelotinib |
JAK1/2 inhibitor |
Pazopanib |
PDGFR and VEGFR; Also c-KIT, FGFR, inhibitor |
||
resveratrol |
SirT1 activator (?) |
TBB |
Casein kinase II inhibitor |
Nilotinib |
Multikinase inhibitor |
||
EX527 |
SirT1 inhib |
Roscovitine |
Cdk5 inhibitor |
lenalidomide |
immunomodulator |
||
salermide |
SirT1 inhib; SirT2 inhib |
Rolipram |
PDE4 inhibitor |
AR A014418 |
GSK3 inhibitor |
||
geldanamycin |
HSP90 inhibitor |
RGFP966 |
HDAC3 inhibitor |
BMS-345541 |
IkKB inhibitor |
||
rapamycin |
mTOR inhibitor |
sotrastaurin |
inhibitor of protein kinase C beta |
IPI-145 |
Ras/PI3K-P110g,d inhibitor |
||
staurosporine |
Kinase inhibitor; general |
staurosporine |
Kinase inhibitor; general |
staurosporine |
Kinase inhibitor; general |
||
LY-294002 |
Kinase inhibitor; pim-1, PI3k |
CHIR99021 |
GSK3 inhibitor |
PS-1145 |
IkK inhibitor |